Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. https://doi.org/10.3322/caac.21834From NLM Medline

Article  PubMed  Google Scholar 

Farkas AH, Nattinger AB (2023) Breast cancer screening and prevention. Ann Intern Med 176(11):ITC161–ITC176. https://doi.org/10.7326/AITC202311210 IF: 15.2 Q1 B1 From NLM Medline

Article  PubMed  Google Scholar 

Zhang X (2023) Molecular classification of breast cancer: relevance and challenges. Arch Pathol Lab Med 147(1):46–51. https://doi.org/10.5858/arpa2022-0070-RA From NLM Medline

Article  PubMed  Google Scholar 

Ben-Dror J, Shalamov M, Sonnenblick A (2022) The history of early breast cancer treatment. Genes (Basel) 13(6):960. https://doi.org/10.3390/genes13060960 IF: 2.8 Q2 B3 From NLM Medline

Pereira JD, Tosatti JAG, Simoes R, Luizon MR, Gomes KB, Alves MT (2020) MicroRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis. Biomed Pharmacother 131:110709. https://doi.org/10.1016/j.biopha.2020.110709From NLM Medline

Article  CAS  PubMed  Google Scholar 

Lev S (2020) Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochem Soc Trans 48(2):657–665. https://doi.org/10.1042/BST20191055 IF: 4.3 Q2 B2 From NLM Medline

Article  CAS  PubMed  Google Scholar 

Dvir K, Giordano S, Leone JP (2024) Immunotherapy in breast cancer. Int J Mol Sci 25(14). https://doi.org/10.3390/ijms25147517From NLM Medline

Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79(18):4557–4566. https://doi.org/10.1158/0008-5472.CAN-18-3962From NLM Medline

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hay ZLZ, Slansky JE, Granzymes (2022) The molecular executors of Immune-Mediated cytotoxicity. Int J Mol Sci 23(3). https://doi.org/10.3390/ijms23031833From NLM Medline

Freen-van Heeren JJ (2024) Posttranscriptional events orchestrate immune homeostasis of CD8(+) T cells. Methods Mol Biol 2782:65–80. https://doi.org/10.1007/978-1-0716-3754-8_4From NLM Medline

Article  CAS  PubMed  Google Scholar 

Lu F, Yan G, Zhao Z, Zheng Z, Wu Y, Wen L, Liu Y, Zeng Q, Zhang G (2025) TDO2 + cancer-associated fibroblasts mediate cutaneous squamous cell carcinoma immune escape via impeding infiltration of CD8 + T cells. Cancer Immunol Immunother 74(2):67. https://doi.org/10.1007/s00262-024-03921-0From NLM Medline

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou X, Chen Z, Yu Y, Li M, Cao Y, Prochownik EV, Li Y (2024) Increases in 4-Acetaminobutyric acid generated by phosphomevalonate kinase suppress CD8(+) T cell activation and allow tumor immune escape. Adv Sci (Weinh) 11(43):e2403629. https://doi.org/10.1002/advs.202403629From NLM Medline

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rong D, Sun G, Zheng Z, Liu L, Chen X, Wu F, Gu Y, Dai Y, Zhong W, Hao X et al (2022) MGP promotes CD8(+) T cell exhaustion by activating the NF-kappaB pathway leading to liver metastasis of colorectal cancer. Int J Biol Sci 18(6):2345–2361. https://doi.org/10.7150/ijbs.70137From NLM Medline

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ge W, Yue M, Lin R, Zhou T, Xu H, Wang Y, Mao T, Li S, Wu X, Zhang X et al (2023) PLA2G2A(+) cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8(+) cytotoxic T cells. Cancer Lett 558:216095. https://doi.org/10.1016/j.canlet.2023.216095From NLM Medline

Article  CAS  PubMed  Google Scholar 

Zeng S, Hu H, Li Z, Hu Q, Shen R, Li M, Liang Y, Mao Z, Zhang Y, Zhan W et al (2024) Local TSH/TSHR signaling promotes CD8(+) T cell exhaustion and immune evasion in colorectal carcinoma. Cancer Commun (Lond) 44(11):1287–1310. https://doi.org/10.1002/cac2.12605From NLM Medline

Article  PubMed  PubMed Central  Google Scholar 

Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H, Zeng Q, Wang Y, Jin F, Chai C et al (2021) Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion. J Exp Clin Cancer Res 40(1):4. https://doi.org/10.1186/s13046-020-01786-6From NLM Medline

Article  CAS  PubMed  PubMed Central  Google Scholar 

Certo M, Tsai CH, Pucino V, Ho PC, Mauro C (2021) Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol 21(3):151–161. https://doi.org/10.1038/s41577-020-0406-2From NLM Medline

Article  CAS  PubMed  Google Scholar 

Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, Wu Q, Li S, Luo S, Li M et al (2022) Aerobic Glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha. Cell Metab 34(9):1312–1324e1316. https://doi.org/10.1016/j.cmet.2022.08.002From NLM Medline

Article  CAS  PubMed  Google Scholar 

Dibley MG, Formosa LE, Lyu B, Reljic B, McGann D, Muellner-Wong L, Kraus F, Sharpe AJ, Stroud DA, Ryan MT (2020) The mitochondrial Acyl-carrier protein interaction network highlights important roles for LYRM family members in complex I and mitoribosome assembly. Mol Cell Proteom 19(1):65–77. https://doi.org/10.1074/mcp.RA119.001784From NLM Medline

Article  CAS  Google Scholar 

Wang HY, Xie Y, Du H, Luo B, Li Z (2023) High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration. PeerJ 11:e16104. https://doi.org/10.7717/peerj.16104From NLM Medline

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Liu JC, Ju Y, Pellecchia G, Voisin V, Wang DY, Leha LR, Ben-David Y, Bader GD, Zacksenhaus E (2017) microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer. JCI Insight 2(15). https://doi.org/10.1172/jci.insight.93313From NLM PubMed-not-MEDLINE

Guo S, Mao Z, Zhang G, Xu B, He X (2022) CircPTN promotes angiogenesis via the MiR-595/LYRM5 signaling pathway in non-small cell lung cancer. Transl Cancer Res 11(3):519–529. https://doi.org/10.21037/tcr-22-195From NLM PubMed-not-MEDLINE

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pang Y, Tan G, Yang X, Lin Y, Chen Y, Zhang J, Xie T, Zhou H, Fang J, Zhao Q et al (2021) Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. Cancer Cell Int 21(1):463. https://doi.org/10.1186/s12935-021-02131-3From NLM PubMed-not-MEDLINE

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Fang T, Lv Y (2022) A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer. Front Genet 13:934830. https://doi.org/10.3389/fgene.2022.934830From NLM PubMed-not-MEDLINE

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gene expression profiling interactive analysis (2018) http://gepia2.cancer-pku.cn/

Kaplan-Meier (2025) plotter. https://kmplot.com

TIMER2 (2020) http://timer.cistrome.org/

RM2Target (2025) http://rm2target.canceromics.org/

Predictors for RNA N6-methyladenosine (m6A) modification site. (2025) http://www.cuilab.cn/sramp

He L, Li H, Wu A, Peng Y, Shu G, Yin G (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18(1):176. https://doi.org/10.1186/s12943-019-1109-9From NLM Medline

Article  PubMed  PubMed Central  Google Scholar 

Wei W, Zhang ZY, Shi B, Cai Y, Zhang HS, Sun CL, Fei YF, Zhong W, Zhang S, Wang C et al (2023) METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. J Exp Clin Cancer Res 42(1):151. https://doi.org/10.1186/s13046-023-02732-yFrom NLM Medline

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu L, Zheng D, Qu J, Zhuang Y, Peng J, Lan S, Zhang S, Huang F (2022) METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Front Cell Dev Biol 10:759020. https://doi.org/10.3389/fcell.2022.759020From NLM PubMed-not-MEDLINE

Article  PubMed  PubMed Central  Google Scholar 

Shinde A, Chandak N, Singh J, Roy M, Mane M, Tang X, Vasiyani H, Currim F, Gohel D, Shukla S et al (2024) TNF-alpha induced NF-kappaB mediated LYRM7 expression modulates the tumor growth and metastatic ability in breast cancer. Free Radic Biol Med 211:158–170. https://doi.org/10.1016/j.freeradbiomed.2023.12.018From NLM Medline

Article  CAS  PubMed